海利生物：拟调整认购上海润瓴并购基金份额

格隆汇12-23

（原标题：海利生物(603718.SH)：拟调整认购上海润瓴并购基金份额）格隆汇12月23日丨海利生物(603718.SH)公布，近日，公司收到上海润瓴并购基金普通合伙人、执行事务合伙人暨基金管理人无锡灏瓴投资管理合伙企业（有限合伙）（简称“无锡灏瓴”）发出的变更通知，上海润瓴并购基金的认缴出资总额拟由65,000万元人民币调整为12,270万元人民币。鉴于目前上海润瓴并购基金已经进入退出期，考虑...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2493806087?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-23 15:39","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2493806087","market":"sh","top_or_hot":-1,"title":"海利生物：拟调整认购上海润瓴并购基金份额","media":"格隆汇","content":"<div>\n<p>（原标题：海利生物(603718.SH)：拟调整认购上海润瓴并购基金份额）格隆汇12月23日丨海利生物(603718.SH)公布，近日，公司收到上海润瓴并购基金普通合伙人、执行事务合伙人暨基金管理人无锡灏瓴投资管理合伙企业（有限合伙）（简称“无锡灏瓴”）发出的变更通知，上海润瓴并购基金的认缴出资总额拟由65,000万元人民币调整为12,270万元人民币。鉴于目前上海润瓴并购基金已经进入退出期，考虑...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223155558a2041ec1&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>海利生物：拟调整认购上海润瓴并购基金份额</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n海利生物：拟调整认购上海润瓴并购基金份额\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-23 15:39 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223155558a2041ec1&s=b><strong>格隆汇</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>（原标题：海利生物(603718.SH)：拟调整认购上海润瓴并购基金份额）格隆汇12月23日丨海利生物(603718.SH)公布，近日，公司收到上海润瓴并购基金普通合伙人、执行事务合伙人暨基金管理人无锡灏瓴投资管理合伙企业（有限合伙）（简称“无锡灏瓴”）发出的变更通知，上海润瓴并购基金的认缴出资总额拟由65,000万元人民币调整为12,270万元人民币。鉴于目前上海润瓴并购基金已经进入退出期，考虑...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223155558a2041ec1&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223155558a2041ec1&s=b","article_id":"2493806087","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223155558a2041ec1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2493806087","pubTimestamp":1734939571,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"格隆汇12月23日丨海利生物公布，近日，公司收到上海润瓴并购基金普通合伙人、执行事务合伙人暨基金管理人无锡灏瓴投资管理合伙企业发出的变更通知，上海润瓴并购基金的认缴出资总额拟由65,000万元人民币调整为12,270万元人民币。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603718":"海利生物","BK0239":"医药制造","BK0046":"生物疫苗","BK0070":"员工持股"},"translate_title":"Haili Bio: Plans to adjust the subscription of Shanghai Runling M&A Fund shares","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603718":1},"content_text":"（原标题：海利生物(603718.SH)：拟调整认购上海润瓴并购基金份额）格隆汇12月23日丨海利生物(603718.SH)公布，近日，公司收到上海润瓴并购基金普通合伙人、执行事务合伙人暨基金管理人无锡灏瓴投资管理合伙企业（有限合伙）（简称“无锡灏瓴”）发出的变更通知，上海润瓴并购基金的认缴出资总额拟由65,000万元人民币调整为12,270万元人民币。鉴于目前上海润瓴并购基金已经进入退出期，考虑到政策法规、市场环境、行业周期等诸多因素的变化，并根据合伙协议第3.3.7条“普通合伙人可自行决定缩小本有限合伙企业认缴出资总额，停止接受后期出资，但不得使认缴出资总额低于人民币3,000万元”的相关约定，上海润瓴并购基金普通合伙人、执行事务合伙人暨基金管理人无锡灏瓴向全体合伙人发出通知缩减上海润瓴并购基金的认缴出资总额，将上海润瓴并购基金的认缴出资总额由65,000万元人民币调整为12,270万元人民币。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2493806087"}